Results 121 to 130 of about 13,391 (192)

METTL3 in esophageal cancer: Current insights into molecular mechanisms, subtype heterogeneity and targeted therapy prospects (Review). [PDF]

Int J Oncol
Pu C, Hu H, Fan H, Chen T, Tang J.
europepmc   +1 more source

METTL14 inhibits atherogenesis by epigenetically activating PPAR-α/γ transcription and fatty acid oxidation in VSMCs. [PDF]

Cardiovasc Res
Cui L, Ho CK, Liang P, Gao W, Liu J, Tian XY, Wong R, Zhou B, Lui KO.   +8 more
europepmc   +1 more source

METTL3-mediated m⁶A modification of lncRNA MALAT1 promotes colorectal cancer progression by activating the NF-κB signaling pathway. [PDF]

J Transl Med
Lin S, Zeng H, Xue X, Liao B, Lin H, Wang Y, Xu D.   +6 more
europepmc   +1 more source

Regulatory mechanisms and therapeutic potential of N6-methyladenosine modification in retinal diseases (Review). [PDF]

Mol Med Rep
Zhang W, Chen J, Zhong J.
europepmc   +1 more source

Revisiting down syndrome through the lens of interferonopathy and innate immune dysregulation. [PDF]

Front Immunol
Wang G, Shi W, Liao S, Hao B.
europepmc   +1 more source

m⁶A RNA modification guides alternative polyadenylation to maintain T cell quiescence. [PDF]

Sci Adv
Zhang X, Li H, Wang G, Miao S, Hao Y, Li S, Li B, Xiao H, Su B, Wu Y, Ye Y, Li HB.   +11 more
europepmc   +1 more source

Reviewer #1 (Public Review): A cleaved METTL3 potentiates the METTL3–WTAP interaction and breast cancer progression

, 2023
openaire   +2 more sources

METTL3-IGF2BP3 as a glucose sensor in hyperglycemic microenvironment promotes tumorigenesis and glycolysis. [PDF]

Int J Biol Sci
Liu L, Zhang Y, Shao Z, Zhao X, Huang Y, Wang Q, Liu X, Zheng X, Zhou B, Zhang F, Gao Z, Yan S.   +11 more
europepmc   +1 more source

METTL3-mediated m⁶A modification stabilizes circCDK6 to promote cervical cancer tumorigenesis via the miR-449a/CDK6 axis. [PDF]

Sci Rep
Zhong P, Li W, Feng M, Guo A, Wang L, Wu Z.   +5 more
europepmc   +1 more source

Reviewer #2 (Public Review): A cleaved METTL3 potentiates the METTL3–WTAP interaction and breast cancer progression

, 2023
openaire   +2 more sources